Sessions
A Fireside Chat With Our Keynote Speaker
9:35 AM - 10:20 AM Tue
A Panel Discussion with FDA Regulators
4:00 PM - 4:45 PM Tue
Panel Discussion with the Keynote Speakers
2:25 PM - 3:00 PM Wed
Supply Chain Visibility: A Regulatory Necessity and Business Imperative
9:35 AM - 10:20 AM Thu
Overcoming Supply Chain Challenges & Opportunities
4:00 PM - 4:45 PM Thu
Daniel R. Matlis is President and Founder Axendia, Inc. an analyst firm providing trusted advice to Life-Science Executives on Business, Technology and Regulatory issues.
Dan has over three decades of industry experience spanning the Life-Science value chain.
He is an active contributor to FDA’s Case for Quality Initiative (since 2014), is a member of FDA’s Advisory Council on Modeling, Simulation and in-Silico Clinical Trial, and co-chaired the Product Quality Outcomes Analytics initiative with Agency officials. He has also provided input to the Agency on guidance on “Computer Software Assurance for Production and Quality System Software.”
Dan began his career at Johnson & Johnson, where he provided leadership in the areas of technology, regulatory compliance and business. Before founding Axendia, Dan was a Partner, VP and General Manager at a leading Life-Science consultancy firm.
He is a frequent lecturer at Industry events and has presented Axendia’s research findings to industry executives and the FDA officials. He has published numerous research reports, eBooks, and articles on key issues facing the Life-Sciences and Healthcare industries.
In 2021, Dan was named one of the Top 20 Life Science Influencers to follow by Dot Compliance.
Dan holds a BS in Electrical Engineering from Polytechnic University (now NYU School of Engineering) in NY and a MS in Management from the New Jersey Institute of Technology.